Abstract
Background: Salivary clear cell carcinoma is an uncommon, low-grade malignancy for which limited data describing predictive clinicopathologic factors and treatment outcomes exist because of rarity. Methods: The authors queried the Surveillance, Epidemiology, and End Results database from 1982 to 2014. Multivariate Cox and Kaplan-Meier analyses were performed to determine disease-specific survival (DSS) and predictive clinicopathologic factors. Results: One hundred ninety-eight patients with salivary clear cell carcinoma were included. Overall incidence was 0.011 per 100 000 individuals, with no significant annual percentage change across years (−0.93%, P =.632). Five-, 10-, and 20-year DSS rates were 81.3% (n = 117), 69.6% (n = 94), and 55.3% (n = 68), respectively. Men (hazard ratio, 4.74; P =.0087) and patients with regional (hazard ratio, 5.59; P =.018) or distant (hazard ratio, 8.9; P =.01) metastases carried a worse prognosis. Five-year DSS was greater in patients with localized disease (96.36%, P
Author supplied keywords
Cite
CITATION STYLE
Sharbel, D. D., Unsal, A. A., Groves, M. W., Albergotti, W. G., & Byrd, J. K. (2019). Salivary Clear Cell Carcinoma Clinicopathologic Characteristics and Outcomes: A Population-Based Analysis. Annals of Otology, Rhinology and Laryngology, 128(11), 989–996. https://doi.org/10.1177/0003489419853597
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.